Zoetis Inc. (0M3Q.L)

USD 169.5

(-0.56%)

EBITDA Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual EBITDA in 2023 was 3.68 Billion USD , up 17.18% from previous year.
  • Zoetis Inc.'s latest quarterly EBITDA in 2024 Q3 was 955 Million USD , up 2.23% from previous quarter.
  • Zoetis Inc. reported an annual EBITDA of 3.35 Billion USD in 2022, up 4.18% from previous year.
  • Zoetis Inc. reported an annual EBITDA of 3.17 Billion USD in 2021, up 6.85% from previous year.
  • Zoetis Inc. reported a quarterly EBITDA of 927 Million USD for 2024 Q1, up 11.02% from previous quarter.
  • Zoetis Inc. reported a quarterly EBITDA of 955 Million USD for 2024 Q3, up 2.23% from previous quarter.

Annual EBITDA Chart of Zoetis Inc. (2023 - 2009)

Historical Annual EBITDA of Zoetis Inc. (2023 - 2009)

Year EBITDA EBITDA Growth
2023 3.68 Billion USD 17.18%
2022 3.35 Billion USD 4.18%
2021 3.17 Billion USD 6.85%
2020 2.68 Billion USD 22.38%
2019 2.45 Billion USD 7.16%
2018 2.21 Billion USD 14.97%
2017 1.94 Billion USD 21.97%
2016 1.63 Billion USD 41.33%
2015 868 Million USD 2.74%
2014 1.14 Billion USD 14.96%
2013 1.01 Billion USD -16.29%
2012 941 Million USD 23.78%
2011 635 Million USD 72.29%
2010 400 Million USD 44.35%
2009 2 Million USD 0.0%

Peer EBITDA Comparison of Zoetis Inc.

Name EBITDA EBITDA Difference
Editas Medicine, Inc. -163.11 Million USD 2359.115%
Dynavax Technologies Corporation 9.66 Million USD -38023.319%
Supernus Pharmaceuticals, Inc. 98.26 Million USD -3650.178%
Perrigo Company plc 646.2 Million USD -470.257%
Illumina, Inc. -608 Million USD 706.086%
Thermo Fisher Scientific Inc. 10.8 Billion USD 65.88%
Iovance Biotherapeutics, Inc. -449.01 Million USD 920.689%
Walgreens Boots Alliance, Inc. -11.27 Billion USD 132.674%
IQVIA Holdings Inc. 3.25 Billion USD -13.176%
Heron Therapeutics, Inc. -103.79 Million USD 3650.37%
Regeneron Pharmaceuticals, Inc. 4.65 Billion USD 20.824%
Unity Biotechnology, Inc. -37.28 Million USD 9983.861%
Waters Corporation 1.02 Billion USD -260.479%
Biogen Inc. 2.37 Billion USD -55.027%
Sangamo Therapeutics, Inc. -87.42 Million USD 4314.945%
Evolus, Inc. -41.81 Million USD 8913.681%
Adicet Bio, Inc. -136.53 Million USD 2798.942%
Cara Therapeutics, Inc. -117.65 Million USD 3232.172%
bluebird bio, Inc. -167.16 Million USD 2304.462%
Esperion Therapeutics, Inc. -150.1 Million USD 2554.899%
FibroGen, Inc. -261.4 Million USD 1509.69%
Agilent Technologies, Inc. 1.67 Billion USD -119.738%
Corbus Pharmaceuticals Holdings, Inc. -44.43 Million USD 8392.695%
Homology Medicines, Inc. -47.75 Million USD 7816.308%
Geron Corporation -174.78 Million USD 2208.341%
Alnylam Pharmaceuticals, Inc. -228.12 Million USD 1715.371%
Amicus Therapeutics, Inc. -92.07 Million USD 4101.998%
Myriad Genetics, Inc. -67.8 Million USD 5535.103%
Viking Therapeutics, Inc. -100.82 Million USD 3754.775%
Intellia Therapeutics, Inc. -506.31 Million USD 827.808%
Abeona Therapeutics Inc. -50.57 Million USD 7386.641%
Mettler-Toledo International Inc. 1.16 Billion USD -216.568%
BioMarin Pharmaceutical Inc. 310.28 Million USD -1087.622%
Vertex Pharmaceuticals Incorporated 4.6 Billion USD 19.982%
Kala Pharmaceuticals, Inc. -36.08 Million USD 10312.849%
Ionis Pharmaceuticals, Inc. -230.01 Million USD 1702.104%
Atara Biotherapeutics, Inc. -265.99 Million USD 1485.354%
Verastem, Inc. -83.16 Million USD 4530.897%
Nektar Therapeutics -243.1 Million USD 1615.793%
Axsome Therapeutics, Inc. -224.99 Million USD 1737.843%
Aclaris Therapeutics, Inc. -87.98 Million USD 4288.214%
Sarepta Therapeutics, Inc. -439.19 Million USD 939.033%
OPKO Health, Inc. -65.51 Million USD 5724.58%
Exelixis, Inc. 196.6 Million USD -1774.345%
Neurocrine Biosciences, Inc. 416.1 Million USD -785.604%
Corcept Therapeutics Incorporated 108.32 Million USD -3301.832%
Anavex Life Sciences Corp. -55.75 Million USD 6709.154%
uniQure N.V. -253.1 Million USD 1555.946%
Imunon, Inc. -20.78 Million USD 17831.456%
Blueprint Medicines Corporation -474.61 Million USD 876.424%
Insmed Incorporated -654.73 Million USD 662.82%
Halozyme Therapeutics, Inc. 451.94 Million USD -715.361%
Agios Pharmaceuticals, Inc. -345.46 Million USD 1166.678%
TG Therapeutics, Inc. 26.1 Million USD -14018.774%
Incyte Corporation 919.42 Million USD -300.794%
Emergent BioSolutions Inc. -505.29 Million USD 829.27%